Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment.
Middle East Liver Disease (MELD) Center, Tehran, Iran. Electronic address: h.sharafi@meldcenter.com.
Heidar
H
Sharafi
Middle East Liver Disease (MELD) Center, Tehran, Iran.
Seyed Moayed
SM
Alavian
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran. Electronic address: m.keshvari@ibto.ir.
Maryam
M
Keshvari
D000998:Antiviral Agents / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin